Spyre Therapeutics, Inc. financial statements
Spyre Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | 10-K |
| Net income | −USD 155.2M | 10-K |
| Cash and equivalents | USD 85.72M | 10-Q |
Spyre Therapeutics, Inc. financials on 6ix · Spyre Therapeutics, Inc. on 6ix